Our Medicines

Innovative Medicines

The first commercial success for ApoPharma was in 1999 with Ferriprox®*(deferiprone). Ferriprox® is now commercially available in over 60 countries where it serves a key role in reducing morbidity in many patients. For specific information on Ferriprox® and how to access it in your country, we encourage you to contact us at productinfo@apopharma.com.



A tried and tested product for decades, but a new addition to the ApoPharma product portfolio in the USA is Alkeran®** (melphalan) tablets. For specific information on Alkeran® and how to access it in the USA, we encourage you to contact us at productinfo@apopharma.com.



*Ferriprox is a registered trademark of Apotex Inc.
**Alkeran is a registered trademark of GlaxoSmithKline.

Leaving ApoPharma.com

You are now leaving ApoPharma Inc. This link will take you to a web site where this site’s Privacy Policy does not apply. You are solely responsible for your interactions with that web site. We encourage you to read the privacy policy of every Web site you visit.

CONTINUE RETURN TO APOPHARMA.COM

Leaving ApoPharma.com

You have expressed an interest in looking at job openings for ApoPharma Inc. You are now leaving the ApoPharma website and entering the Apotex website. Do not be concerned, ApoPharma is a part of the Apotex group of companies. All job openings for Apotex member companies, including those for ApoPharma Inc. are found on this website.

CONTINUE RETURN TO APOPHARMA.COM